abemaciclib’s value in treating hr breast cancer
Published 6 years ago • 918 plays • Length 5:21Download video MP4
Download video MP3
Similar videos
-
1:39
dr. ellis on abemaciclib in hr-positive breast cancer
-
7:09
abemaciclib for hr-positive metastatic breast cancer
-
1:19
advantages to treating hr patients with breast cancer with abemaciclib
-
0:52
exploring abemaciclib for the treatment of brain metastases in hr /her2- breast cancer
-
1:12
monarche: adjuvant abemaciclib in hr breast cancer
-
2:37
#esmo22 highlights on abemaciclib nsai in hr /her2- advanced breast cancer: the monarch 3 study
-
4:45
abemaciclib monotherapy’s role in hr breast cancer
-
16:00
foundation frontiers: advanced breast cancer - updates to hr /her2- treatment landscape
-
5:04
abemaciclib fulvestrant at progression of hr mbc
-
6:15
abemaciclib with hormone therapy for hr mbc
-
1:41
dr. harold j. burstein on cdk4/cdk6 inhibitor abemaciclib in breast cancer
-
1:41
dr. tolaney on activity with abemaciclib in patients with hr /her2– breast cancer
-
1:41
postmonarch: abemaciclib with fulvestrant in pretreated hr /her2- breast cancer
-
0:22
copy of dr. ellis on abemaciclib in hr-positive breast cancer
-
4:35
hr breast cancer: differences between cdk4/6 inhibitors
-
7:35
fda approval for abemaciclib
-
2:42
phase ii results for abemaciclib in pretreated hr /her2-negative breast cancer
-
1:39
abemaciclib for hr /her2- advanced or metastatic breast cancer
-
4:19
monarche results: abemaciclib plus endocrine therapy in high-risk early breast cancer